Last medical review:

What is neuroblastoma?

Neuroblastoma starts in immature nerve cells in the sympathetic nervous system. It most commonly occurs in babies and young children.

Risk factors for neuroblastoma

Certain inherited genetic syndromes can increase a child's risk of developing neuroblastoma.

Symptoms of neuroblastoma

Common signs and symptoms of neuroblastoma include a lump in the abdomen, swelling in the abdomen and bulging of the eyes.

Diagnosis of neuroblastoma

Tests such as urine, blood tests and ultrasound can be used to diagnose or rule out neuroblastoma.

Stages of neuroblastoma

The stage of neuroblastoma describes how much cancer is in the body. Different staging systems are used to stage neuroblastoma.

If neuroblastoma spreads

Neuroblastoma can spread (metastasize) to the lymph nodes, bone and bone marrow.

Prognosis and survival for neuroblastoma

Prognosis estimates the outcome for neuroblastoma. It depends on many factors including age, stage and tumour histology.

Treatments for neuroblastoma

Neuroblastoma can be treated with surgery, chemotherapy, radiation, stem cell transplant, retinoids and immunotherapy.

Supportive care

Supportive care for neuroblastoma helps children and their families meet physical, emotional and spiritual challenges.

Neuroblastoma statistics

Cancer statistics tell us how many people in Canada are diagnosed with and die from neuroblastoma in a certain time frame.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on, nor do we endorse any service, product, treatment or therapy.

1-888-939-3333 | | © 2024 Canadian Cancer Society